Search

for
Search:

GlossaryTeriflunomide

medication used to treat multiple sclerosis by reducing immune activity

Teriflunomide is a medication primarily used to treat multiple sclerosis (MS), a condition where the immune system attacks the protective covering of nerves. It works by inhibiting the function of certain immune cells, thereby reducing inflammation and the frequency of MS flare-ups.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 25 results

research Teriflunomide and Its Mechanism of Action in Multiple Sclerosis

253 citations, April 2014 in “Drugs”

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

research Pooled Safety and Tolerability Data from Four Placebo-Controlled Teriflunomide Studies and Extensions

72 citations, November 2015 in “Multiple Sclerosis and Related Disorders”

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

research Teriflunomide (Aubagio) for the Treatment of Multiple Sclerosis

36 citations, June 2014 in “Experimental Neurology”

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

research Teriflunomide in Patients with Relapsing-Remitting Forms of Multiple Sclerosis

29 citations, January 2016 in “CNS drugs”

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

research Teriflunomide in Multiple Sclerosis: An Update

20 citations, December 2016 in “Neurodegenerative disease management”

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

View more "teriflunomide" in research →

Community Join

0 / 0 results

— no results